Short-term effects of intravitreal triamcinolone on retinal vascular leakage and trunk vessel diameters in diabetic macular oedema

Acta Ophthalmologica Scandinavica

Volumn 85, Issue 1, 2007, Pages 21-26

  Vinten, Martin ^a   Larsen, Michael ^a   Lund Andersen, Henrik ^a   Sander, Birgit ^a   La Cour, Morten ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Diabetic macular oedema; Optical coherence tomography; Retina; Triamcinolone; Vitreous fluorophotometry

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTERY DIAMETER; ARTICLE; BLOOD EYE BARRIER; BLOOD VESSEL DIAMETER; BLOOD VESSEL PERMEABILITY; CASE STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC MACULAR EDEMA; FLUOROPHOTOMETRY; HUMAN; LASER COAGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OCULAR BLOOD VESSEL; OPEN STUDY; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REFERENCE VALUE; RETINA DISEASE; RETINA FOVEA; VEIN DIAMETER; VISUAL ACUITY;

AGED; BLOOD-RETINAL BARRIER; CAPILLARY PERMEABILITY; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FLUOROPHOTOMETRY; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MACULAR EDEMA, CYSTOID; MIDDLE AGED; RETINAL VESSELS; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE ACETONIDE; VITREOUS BODY;

EID: 33846405657     PISSN: 13953907     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2006.00806.x     Document Type: Article

References (19)

1. Early Treatment Diabetic Retinopathy Study Research Group (1985): Photocoagulation for diabetic macular oedema. Early Treatment Diabetic Retinopathy Study Report 1. Arch Ophthalmol 103: 1796-1806.
2. Edelman JL, Lutz D & Castro MR (2005): Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown. Exp Eye Res 80: 249-258.
3. Jonas JB, Akkoyun I, Kreissig I & Degenring RF (2005): Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomized study. Br J Ophthalmol 89: 321-326.
4. Kristinsson JK, Gottfredsdottir MS & Stefansson E (1997): Retinal vessel dilatation and elongation precedes diabetic macular oedema. Br J Ophthalmol 81: 274-278.
5. Krogsaa B, Lund-Andersen H, Mehlsen J, Sestoft L & Larsen J (1981): The blood-retinal barrier permeability in diabetic patients. Acta Ophthalmol (Copenh) 59: 689-694.
6. Larsen M, Colmorn LB, Bonnelycke M, Kaaja R, Immonen I, Sander B & Loukovaara S (2005): Retinal artery and vein diameters during pregnancy in diabetic women. Invest Ophthalmol Vis Sci 46: 709-713.
7. Larsen M, Dalgaard P & Lund-Andersen H (1991): Determination of spatial co-ordinates in ocular fluorometry. Graefes Arch Clin Exp Ophthalmol 229: 358-362.
8. Larsen M & Lund-Andersen H (1991): Lens fluorometry: light-attenuation effects and estimation of total lens transmittance. Graefes Arch Clin Exp Ophthalmol 229: 363-370.
9. Lobo C, Bernardes R, d'Faria A Jr & Cunha-Vaz JG (1999): Novel imaging techniques for diabetic macular oedema. Doc Ophthalmol 97: 341-347.
10. Lund-Andersen H, Krogsaa B, la Cour M & Larsen J (1985): Quantitative vitreous fluorophotometry applying a mathematical model of the eye. Invest Ophthalmol Vis Sci 26: 698-710.
11. Massin P, Vicaut E, Haouchine B, Erginay A, Paques M & Gaudric A (2001): Reproducibility of retinal mapping using optical coherence tomography. Arch Ophthalmol 119: 1135-1142.
12. Nagel E & Vilser W (2004): Autoregulative behaviour of retinal arteries and veins during changes of perfusion pressure: A clinical study. Graefes Arch Clin Exp Ophthalmol 242: 13-17.
13. Perretti M & Ahluwalia A (2000): The microcirculation and inflammation: Site of action for glucocorticoids. Microcirculation 7: 147-161.
14. Riva CE, Grunwald JE, Sinclair SH & Petrig BL (1985): Blood velocity and volumetric flow rate in human retinal vessels. Invest Ophthalmol Vis Sci 26: 1124-1132.
15. Sander B, Larsen M, Engler C, Strom C, Moldow B, Larsen N & Lund-Andersen H (20A2): Diabetic macular oedema: a comparison of vitreous fluorometry, angiography and retinopathy. Br J Ophthalmol 86: 316-320.
16. Sander B, Larsen M, Moldow B & Lund-Andersen H (2001): Diabetic macular oedema: Passive and active transport of fluorescein through the blood-retina barrier. Invest Ophthalmol Vis Sci 42: 433-438.
17. Sutter FK, Simpson JM & Gillies MC (2004): Intravitreal triamcinolone for diabetic macular oedema that persists after laser treatment: 3-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Ophthalmology 111: 2044-2049.
18. Tamura H, Miyamoto K, Kiryu J, Miyahara S, Katsuta H, Hirose F, Musashi K & Yoshimura N (2005): Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. Invest Ophthalmol Vis Sci 46: 1440-1444.
19. Wilson CA, Berkowitz BA, Sato Y, Ando N, Handa JT & de Juan E Jr (1992): Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol 110: 1155-1159.